FDA Issues Alert on Severe Allergic Reactions Linked to Key Multiple Sclerosis Medications
WASHINGTON — The U.S. Food and Drug Administration has issued a warning advising of severe allergic reactions, including anaphylaxis, tied to widely used multiple sclerosis medications. The concern springs from drugs containing glatiramer acetate, marketed under brand names such as Copaxone and Glatopa, which have been linked to potentially fatal outcomes. Medical professionals worldwide have reported 82 cases of anaphylaxis related to these drugs from December 1996 to May 2024. Among these, 19 occurred in …